
The AQUAMANTYS™ 2.3 Bipolar Sealer:
Improving clinical and economic outcomes for smaller access surgical procedures
|
The AQUAMANTYS™ 2.3 Bipolar Sealer is designed to improve patient outcomes and reduce the cost of medical care. Reducing blood loss improves visualization for the surgeon, results in improved clinical outcomes for the patient and may result in lower costs to the hospital. The smaller diameter electrodes of the AQUAMANTYS 2.3 Bipolar Sealer offer greater control in smaller access procedures while still effectively delivering the benefits of TRANSCOLLATION™ technology. |
Common Applications
Spine Procedures
⁃ Discectomies
⁃ Laminotomies
⁃ Scoliosis
Catalog Number
AQUAMANTYS 2.3 Bipolar Sealer……………………23-113-1

Electrode length
5.74mm (.226")
Electrode diameter
2.34mm (.092")
Center to center spacing between electrodes
4.40mm (.173")
Angle at tip
30 Degrees
Out of body shaft length
129.54 (5.1")
(for reference only)
A New Look at Blood Transfusion: Evaluation of the risks and benefits prompts careful blood management. Joint Commission Perspectives on Patient Safety, January 2007, Volume 7, Issue 1.
Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am. 1999; 81(1):2-10.
Siegel HJ, Sparks DR, Casillas MA, Hong H, Dunham WH. The use of bipolar hemosealing technology in orthopedic oncology: safety and clinical impact. Orthopedics 2008; 31:10.
Hu SS. Blood loss in adult spinal surgery. Eur Spine J. 2004; 13(Suppl 1):S3-5.
Krebs VE, Higuera C, Barsoum WK, Helfand R. Blood Management in Joint Replacement Surgery: What’s in and What’s Out. Orthopedics 2006; 29:801.
Blanchette CM, Wang PF, Joshi AV, Asmussen M, Saunders W, Kruse P. Cost and utilization of blood transfusion associated with spinal surgeries in the United States. Eur Spine J. 2006; 1-11. DOI 10.1007/s00586-006-0066-3.
Candrilli S, Mauskopf J. How much does a hospital day cost? 11th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Philadelphia, PA; 2006.
Snyder BD, Hedequist DJ, Shannon EG. Hemostatic efficacy of bipolar wound sealer as adjunct to wound management in children with neuromuscular scoliosis (abstract). Annual Meeting of the Pediatric Orthopaedic Society of North America, 2007.
Patney MJ. Economic Considerations When Using Transcollation technology to Reduce Blood Transfusions in Total Joint Replacement. Data on file.
Bertone A, Lipson D, Kamei J, Litsky A, Weisbrode S. Effective Bone Hemostasis and Healing Using Radiofrequency and Conductive Fluid. Clin Orthop Relat R 2006 May; 446:278-285
Weeden SH, Schmidt RH, Isabell G. Haemostatic efficacy of a bipolar sealing device in minimally invasive total knee arthroplasty (Abstract). 8th Congress Of The European Federation Of National Associations Of Orthopaedics And Traumatology, 2007. Florence, Italy.
Mont MA, Krebs VJ, Bierbaum BE, Goldberg VS, Ries MD. Hemostasis in primary unilateral knee arthroplasty using a bipolar sealer. Data on file.
Rosenberg AG. Reducing blood loss in total joint surgery with a saline-coupled bipolar sealing technology. J Arthroplasty. 2007; 22(4 Suppl 1):82-5.
Marulanda GA, Ragland PS, Seyler TM, Mont MA. Reduction in blood loss with use of a bipolar sealer for hemostasis in primary total knee arthroplasty. Surg Technol Int. 2005;14:281-6.
Mont MA, Marulanda GA, Ulrich SD, Seyler TM, Delanois RE. Reductions in blood loss with a bipolar sealer in total hip arthroplasty. Expert Rev Med Devices. 2008; 5:125-131.
Blanchette CM, Wang PF, Joshi AV, Kruse P, Asmussen M, Saunders W. Resource utilization and costs of blood management services associated with knee and hip surgeries in US Hospitals. Adv Ther. 2006; 23:54-67.
Rosen MJ. Transcollation technology for primary total joint replacement: Clinical and economic benefits. Data on file.
Small HN, Chisholm SD. Use of a new Transcollation technology to reduce blood loss during instrumented lumbar fusion surgery. Data on file.


